• The correction of the placental dysfunction while pregnancy complicated with oligohydramnion

The correction of the placental dysfunction while pregnancy complicated with oligohydramnion

HEALTH OF WOMAN. 2016.10(116):82–86; doi 10.15574/HW.2016.116.82 
 

The correction of the placental dysfunction while pregnancy complicated with oligohydramnion


Basiuha I. O.

SHEI «Ivano-Frankivsk national medical University»


The objective: assess the state of the phetoplacental complex (PPC) in oligohydramnions based on the study echoscopic violations of utero-placental-fruit blood flow, as well as the development and implementation of the algorithm of treatment and preventive measures to reduce adverse perinatal outcomes with the use of different methods of correction.


Patients and methods. To solve the goal were examined 65 women in the period of 32-36 weeks of pregnancy with oligohydramnion. In all the pregnant women were observed hemodynamic disturbances in the PPC. The study group included 35 pregnant women with oligohydramnion that the traditional treatment of identified pathology has been added donator NO and Energoprojekt L-arginine, combined with a comprehensive medium for 2 weeks in a pregnancy from 27 to 29 weeks, and 33-34 weeks of gestation. The control group included 30 pregnant women with oligohydramnion who received traditional treatment depending on the identified etiological causes.


Results. A clinical-statistical analysis based on the study of the incidence of water shortage, hemodynamic FPC and comparative evaluation of the effectiveness of two methods of correction FPC with water scarcity – the traditional and the proposed (the use of donor of nitric oxide – L-arginine and energoprojekty – inosine).


Conclusion. Using Tivortini in complex and comprehensive medicine for the correction of PPC with oligohydramnion, which is one of the few permitted and certified products in obstetrics, will reduce the number of obstetric and perinatal complications.


Key words: pregnancy, placenta disfunction, oligohydramnions, tivortini, complex medicine (amber acid, nicotinamide, riboxin, Riboflavin mononucleotide).


REFERENCES

1. Babushkina AV. 2009. L-arginin s tochki zreniya dokazatelnoy meditsiny. Ukraуinskiy medichniy chasopis 6(76):43–46.

2. Gnatko EP, Dismasi TA, Matveev AI. 2011. Otsenka funktsionalnogo sostoyaniya endoteliya u zdorovyih beremennyih. Akusherstvo, ginekologiya, reproduktologiya 3:81.

3. Пат. №77984 МПК (2013) А61В 10/00 Спосіб неінвазивної діагностики функціонального стану ендотелію при вагітності. Винахідники: Запорожан ВМ, Коньков ДГ, Галич СР, Луцкер ОЛ. Правовласник: Вінницький національний медичний університет ім. М.І. Пірогова Заявка № 2012 07436, заявл. 19.06.2012 Опубл. 11.03.2013 Бюл. 5.

4. Lipatov IS, Tezikov YuV. 2011. Prognozirovanie i diagnostika platsentarnoy nedostatochnosti na osnove markerov endotelialnoy disfunktsii, detsidualizatsii, apoptoza i kletochnoy proliferatsii. Saratovskiy nauchno-meditsinskiy zhurnal 7;1:52–59.

5. Lubyanaya SS, Strizhakova IV, Manischenkov SN i dr. 2010. Novyiy podhod k terapii platsentarnoy disfunktsii s ispolzovaniem L-arginina. Zdorove zhenshchiny 8(54):27–30.

6. Stryuk RI, Buhonkina YuM, Smirnova VA, Chizhova GV. 2010. Funktsiya endoteliya i matochno-plodovo-platsentarnyiy krovotok u beremennyih s arterialnoy gipertoniey. Kardiologiya 4:18–22.